Prosecution Insights
Last updated: August 18, 2026

Examiner: SCHERBEL, TODD J

Tech Center 3700 • Art Units: 3731 3771 3773 3774 3792 3799

This examiner grants 76% of resolved cases

Performance Statistics

76.2%
Allow Rate
+6.2% vs TC avg
799
Total Applications
+52.3%
Interview Lift
1140
Avg Prosecution Days
Based on 776 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
28.8%
§102 Novelty
34.7%
§103 Obviousness
28.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19028432 ENDOSCOPIC NEEDLE ASSEMBLY Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18672942 OVER THE SCOPE DEVICE AND METHOD FOR TREATING TISSUE USING A PATCH Non-Final OA BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
19073399 NEEDLE ASSEMBLIES CONTAINING ORIENTED NEEDLES AND METHODS FOR PRODUCTION THEREOF Non-Final OA ABBOTT DIABETES CARE INC.
18856984 DEVICE, SYSTEM, AND METHOD FOR TISSUE IDENTIFICATION DURING ROBOTIC SURGERY Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18682524 A SKIN TREATMENT DEVICE Final Rejection KONINKLIJKE PHILIPS N.V.
18098943 SYMPATHETIC NERVOUS SYSTEM RESPONSE TO BLOOD FLOW ALTERATIONS IN RENAL VASCULATURE FOR PATIENT STRATIFICATION IN RENAL DENERVATION Non-Final OA KONINKLIJKE PHILIPS N.V.
18270111 DELIVERY DEVICE FOR PROSTHETIC HEART VALVE WITH AXIAL FORCE ADJUSTMENT DEVICE Non-Final OA Medtronic, Inc.
18972024 TISSUE MANIPULATION AND CUTTING DEVICE AND RELATED METHODS Non-Final OA Wisconsin Alumni Research Foundation
18941103 METHOD AND APPARATUS FOR MANAGING ACUTE ISCHEMIC EVENTS Non-Final OA NEURAVI LIMITED
18912912 SUPER-BORE CATHETER WITH BRAID SUPPORTED FLARED TIP Non-Final OA Neuravi Limited
18036783 DEVICE FOR HEART REPAIR Non-Final OA CARDIOMECH AS

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month